Format

Send to

Choose Destination
J Invest Dermatol. 2011 Jun;131(6):1189-91. doi: 10.1038/jid.2011.45.

Fumarate esters as angiogenesis inhibitors: key to action in psoriasis?

Author information

1
Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia 30322, USA. jarbise@emory.edu

Abstract

Fumarate esters--an oral therapy for psoriasis--are used primarily in Europe, but not at all in the United States. Given that biological therapies are exceedingly expensive and pose an increased risk for infections and malignancy, the need for safer and less expensive therapies for psoriasis is compelling. Nonbiological therapies for psoriasis, including methotrexate and systemic retinoids, carry potentially severe side effects and relatively high cost. Fumarate, a natural product that is generated internally in humans during the Krebs cycle, is an attractive alternative to these therapies. However, the mechanism for fumarate's activity in psoriasis remains unknown.

PMID:
21566578
DOI:
10.1038/jid.2011.45
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center